[Federal Register Volume 84, Number 42 (Monday, March 4, 2019)]
[Notices]
[Pages 7393-7394]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-03846]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Renewal of Cooperative Agreement With the Institut Pasteur
International Network
AGENCY: Office of the Assistant Secretary for Preparedness and Response
(ASPR), Department of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Office of the Assistant Secretary for Preparedness and
Response (ASPR), in the Department of Health and Human Services intends
to provide a Single Source Five Year Cooperative Agreement to Institut
Pasteur International Network (IPIN) through the Pasteur Foundation.
The Cooperative Agreement will support
[[Page 7394]]
continue to guide and support public health capacities to prepare for,
detect, and respond to potential public health emergencies caused by
human influenza viruses, zoonotic diseases, and other emerging
infectious diseases with pandemic potential in West and Central Africa,
and Southeast Asia to support the health security of the United States.
The total proposed cost of the Single Source Cooperative Agreement is
not to exceed $5 million over the five-year life of the Cooperative
Agreement.
DATES:
Project Period: The period of performance is from September 30,
2019 to September 30, 2024.
Award Amount: Estimate $5 million.
FOR FURTHER INFORMATION CONTACT:
Maria Marinissen--Maria .[email protected], (202) 205-4214.
Robin Moudy_[email protected], 202-260-2105.
SUPPLEMENTARY INFORMATION: The Office of the Assistant Secretary for
Preparedness and Response (ASPR), International Policy Branch is the
program office for this Cooperative Agreement:
Single Source Justification: Founded in 1887, Institut Pasteur,
based in Paris, has an international research network with 33
institutes globally committed to advancing science, medicine and public
health, with especially unmatched reach in the Francophone world. This
partnership between ASPR and IPIN gives ASPR access to information and
the ability to build international partner capacity to prepare for,
detect, and respond to potential public health emergencies caused by
human influenza viruses, zoonotic diseases, and other emerging
infectious diseases with pandemic potential in West and Central Africa,
and Southeast Asia that could have an severe impact on the health
security of the United States and its citizens.
The focus will be on countries in West and Central Africa,
Madagascar, and Southeast Asia (Cambodia) where IPIN is the primary
laboratory partner of the host government, although supported
partnerships may extend beyond those countries and regions. Prior to
each annual award, affiliated laboratories will submit their proposed
scope of work, which may be adjusted over the course of the year based
on changing needs and priorities or other exigent circumstances, such
as a critical outbreak response.
The five-year scope of work of the renewed cooperative agreement
will build upon the successes of past activities, including the
following overarching objectives:
Facilitate public health emergency planning, rapid
epidemiologic responses, public health event assessment pursuit to the
IHR, international data or event reporting as determined by the host
government, and assist with emergency management where needed;
Ensure One Health coordination with the WHO, the World
Organization for Animal Health (OIE), national human, animal, and
environmental health agencies, and others as needed to address zoonotic
disease threats.
System in place for medical countermeasures distribution
during a public health emergency and integrating vaccine coverage as
part of national program;
Interoperable, interconnected, electronic real-time
reporting system with emergency operation centers, and risk
communication processes in place;
Improve the quality and scale of public health
surveillance, national epidemiologic data, and infectious diseases
diagnostics;
Develop, produce, acquire, and/or deploy novel infectious
disease surveillance assays and clinical diagnostic tests during an
outbreak;
Strengthen laboratory biosafety and biosecurity systems,
including the ability to scale-up in response to an epidemic caused by
a highly dangerous pathogen;
Real-time reporting system, and risk communication
processes in place.
Please submit an inquiry via the ASPR Program Contact: Dr. Robin
Moudy, [email protected], 202-260-2105.
Authority: Sections 301 and 307 of the Public Health Service Act
(42 U.S.C. 241, 242l).
Dated: February 25, 2019.
Robert P. Kadlec,
Assistant Secretary for Preparedness and Response.
[FR Doc. 2019-03846 Filed 3-1-19; 8:45 am]
BILLING CODE 4150-37-P